Marina V Lebedeva (Marina Lebedeva, M V Lebedeva)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Aortic Dissection

Chronic Kidney Disease

Capillary Electrophoresis

Epidermal Growth Factor Receptor

Top Venues

Terapevticheskii arkhiv

Journal of nephrology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

M V Markina, Ludmila Yu Milovanova, L V Lysenko, Svetlana Yu Milovanova, Alexey V Volkov, Vladimir D Beketov, Marina V Lebedeva, Kirill S Nezhdanov, Sergey V Moiseev
[Anemia of chronic diseases in the early stages of chronic kidney disease as a risk factor for cardiovascular complications in patients with glomerulonephritis]. Terapevticheskii arkhiv 96 (6) (2024)
Ludmila Yu Milovanova, Kirill S Nezhdanov, Svetlana Yu Milovanova, Marina V Lebedeva, Vladimir D Beketov, Alexey V Volkov, Elena S Kamyshova, Aleksandr Yu Suvorov, Sergey V Moiseev
α-Klotho is associated with cardiovascular and all-cause mortality in patients with stage 3b and 4 chronic kidney disease (CKD): a long-term prospective cohort study. Journal of nephrology (2024)
Marina V Lebedeva, Natalia V Chebotareva, Vladimir D Beketov
[Diagnostic and treatment difficulties in kidney damage in the patient with generalized sarcoidosis during COVID-19. Case report]. Terapevticheskii arkhiv 94 (6) (2022)
Natalia V Chebotareva, Anatoliy Vinogradov, Alexander G Brzhozovskiy, Daria N Kashirina, Maria I Indeykina, Anna E Bugrova, Marina V Lebedeva, Sergey Moiseev, Evgeny N Nikolaev, Alexey S Kononikhin
Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease. International journal of molecular sciences 23 (20) (2022)
Ludmila Yu Milovanova, L V Lysenko, Svetlana Yu Milovanova, M V Taranova, V V Kozlov, V A Reshetnikov, Marina V Lebedeva, T V Androsova, D O Zubacheva, Natalia V Chebotareva
[Low serum Klotho level as a predictor of calcification of the heart and blood vessels in patients with CKD stages 2-5D]. Terapevticheskii arkhiv 92 (6) (2020)